Weekly shot aims to shed pounds in major new obesity trial

NCT ID NCT07279194

Summary

This study is testing a new weekly injection called HDM1005 to see if it helps people lose weight and improve related health issues like high blood pressure. About 825 Chinese adults who are overweight or have obesity, but do not have diabetes, will receive the injection or a placebo for one year alongside lifestyle counseling. The main goal is to measure how much body weight participants lose and how many achieve significant weight reduction.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Zhongshan Hoapital

    RECRUITING

    Shanghai, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.